Evaluating the Efficacy of Platelet-rich Plasma Therapy in the Treatment of Androgenic Alopecia

Starting soon · Early Phase 1 · Has a placebo group

Conditions studied: Androgenic Alopecia

In brief

The study team will assess the efficacy of platelet-rich plasma therapy, a special blood product which is from the participant's own body, in the treatment of androgenic alopecia (also known as male pattern hair loss) in females.

Key facts

Study ID

NCT03474718

Run by

Wake Forest University Health Sciences

People needed

16

Starts

2026-10-01

Expected to finish

2027-07-01

Last updated by the study team

2026-08-04

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Female ≥18 years of age at baseline visit.
• Documentation of androgenic alopecia diagnosis as evidenced by one or more clinical features
• Not currently on any treatment for alopecia, or has undergone 2-week washout period if recently on medication(s) for alopecia
• Written informed consent obtained from subject and ability for subject to comply with the requirements of the study

You may not qualify if…

• Pregnant or breastfeeding
• Presence of a condition or abnormality that in the opinion of the Investigator would compromise the safety of the patient or the quality of the data.
• Have an infection, metastatic disease or certain skin conditions (ie. Psoriasis) which could worsen or spread with injections
• Diagnosed with a blood or bleeding disorder
• Diagnosed with anemia
• Currently on anticoagulant therapy

Where it is running

• Wake Forest University Baptist Health — Winston-Salem, North Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.